The S&P 500 has been so incredibly resilient in 2026. It’s been less than two weeks since we rang in the new year, but the broad market has already been rocked with a number of macro events, which I would have thought would pave the way for greater volatility and perhaps downside to kick off 2026.
Source: https://247wallst.com/investing/2026/01/13/2-growth-stocks-w…
Here is how Actinium Pharmaceuticals (ATNM) and Collegium Pharmaceutical (COLL) have performed compared to their sector so far this year.
Software stocks have been hit by fears of competition from artificial intelligence but these five companies can thrive in the AI era, according to Oppenheimer analysts.
Bill Ackman landed his latest buy call with exceptional timing, with stocks gaining close to 3% in a session, just one day after he told the startled public that it’s one of the best times to buy quality stocks.
